Bioequivalence and Bioavailability
Bioavailability: The rate and extent to which an active ingredient or active component of a drug product is absorbed and made available at the site of action is known as bioavailability. The area under the blood or plasma concentration-time curve and the highest concentration are typically used to determine the extent and pace of drug absorption, respectively.
Bioequivalence: Two drug products or two drug formulations are said to be bioequivalent or therapeutically equivalent when they have the same therapeutic impact. This indicates that there is no discernible difference in their rates and levels of absorption at the site of action.
- Absolute Bioavailability
- Relative Bioavailability
- Drug Bioavailability
- Genetic Phenotype
Related Conference of Bioequivalence and Bioavailability
July 25-26, 2024
4th International Conference on Biomedicine & Pharmacotherapy
Prague, Czech Republic
Bioequivalence and Bioavailability Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D